Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Latest round
Venture round
Apr 2018 · 8 yr ago
Team
11-50
employees, estimated range
Grants
$5.3M
7 grants · CORDIS
The money's age
Long since its last round
101 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jan 1, 2025 Won a grant $1.3M · CORDIS Jun 1, 2021 Won a grant $2.2M · CORDIS Sep 6, 2017 Founded per the company register
Funding rounds
RoundDateAmountInvestorsSource
Grant Jan 2025 $1.3M — CORDIS
Grant Apr 2023 $271k — CORDIS
Grant Jun 2022 $301k — CORDIS
Grant Jun 2021 $2.2M — CORDIS
Grant Feb 2021 — — CORDIS
Grant Oct 2020 $662k — CORDIS
Grant Feb 2020 $584k — CORDIS
Venture round Apr 2018 — — find-and-update.company-information.service.gov.uk
Registers and programsofficial lists and records that name the company
Legal entity BIOCLAVIS LIMITED Companies House
Registered 6 Sep 2017

Visa sponsorship

  • United Kingdom · Licensed UK visa sponsor (Skilled Worker)

Visa details by country

Overview

BioClavis is a Glasgow-based R&D and service lab leveraging the proprietary TempO-Seq transcriptomic/genomic platform technology for efficient and affordable transcriptomics in precision diagnostics (including CDx development) and drug or biomarker discovery.

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Clydebank United Kingdom
HQ
Our Office
10-50 est. staff
201 Dumbarton Road, Clydebank, G81 4XJ
company site

Financials

Total raised
$5.3M
Latest round
Grant
Funding rounds
8
Funding rounds
Round Announced Amount
Grant 2025 $1.3M Details
Grant 2023 $271k Details
Grant 2022 $301k Details
Grant 2021 $2.2M Details
Grant 2021 — Details
Grant 2020 $662k Details
Grant 2020 $584k Details
Venture - Series Unknown 2018 — Details